BTK Inhibitor Acquired Resistance Panel

Casandra

Casandra Test Code NG07315Version 1 (DRAFT)

Performing Lab

Lab NeoGenomicsLab Test ID N/ACPT Codes 81233, 81320

BTK Inhibitor Acquired Resistance Panel

Also known as: BTK, BTK acquired resistance

Clinical Use

Order Test

Use

This panel detects mutations in BTK and PLC‑gamma‑2 which are associated with acquired ibrutinib resistance in certain B‑cell neoplasms. It is appropriate for patients with B‑cell neoplasms who have relapsed and/or show acquired (secondary) resistance after an initial response to BTK (Bruton tyrosine kinase) inhibitors.